cognivia feature articles
Ceretin: creating the next generation
Cognitive enhancement is all about improvement. The next step. The next development. The next leap forward. At Cognivia, we're preparing to make that leap with our latest iterations of Ceretin. Read the article »
Eliminating the black-market danger
In recent months, there has been an increase in press coverage and protests regarding black-market cognitive enhancers. At Cognivia, we're doing our best to keep people safe from these harmful imitations. Read the article »
Keeping the PCAG drug-free
Once again, Cognivia is proud to support the PCAG, helping to ensure that the competition remains fair and beyond reproach. The aim of our joint testing programme is to keep the crowds focused on what matters most - the excitement of the Games. Read the article »
Understanding the Senescence Problem
As life expectancy continues on an upward trend in Perplex City due to improved healthcare, diets and lifestyles, neurodegenerative diseases and the normal processes of ageing are accounting for an increasingly large proportion of medical problems. In this article, Dr. Thompson discusses the various ways in which we are attempting to understand and combat senescence.
Guiding Perplex City's future scientists
Everyone can remember at least one exceptional teacher who influenced them when they were younger, guiding them along the way to their future profession and making them see the world in a different way. Prof. Upton, the director of Cognivia's Pivot Programme, knows how important it is that children and teenagers with an interest in science are encouraged and supported through their education, and describes our efforts in this article.
The ethics of cognitive enhancement through genetic engineering
Gene therapy has come a long way since the days of delivering DNA via engineered retroviruses or zinc finger nucleases. With absolute rates of gene modification rapidly approaching 100% using current techniques, it is possible for doctors and scientists to literally edit a person's genome. While there is still much left to discover about cognitive function in the brain and how it relates to the genome, we are now at the point where we can safely and reliably enhance specific cognitive functions through gene therapy. The question is, should we? What social consequences could this momentous undertaking incur? The director of Cognivia Research, Edward Flores, looks at the issues facing us.
about our features
We are pleased to announce that we have a selection of features now available for your location.
At Cognivia, we know how important it is for the public to understand and discuss all of the issues involved in cognitive enhancement. Our scientists play a pivotal role in engaging in dialogue with the public about the research we conduct and the products we develop. The feature articles section we publish here is just one of the ways in which we ensure Perplex City is fully informed of the huge impact that cognitive enhancement can have on our lives.